NEW YORK, Sept. 5 – Cheminformatics company Tripos has struck a deal with Schering AG to help the German drug giant integrate its compound research and inventory data and perform chemical tracking, Tripos said on Wednesday.

Under the deal, Tripos will allow Schering to use its ChemCore tracking system to become more efficient in the way it develops novel chemical entities, Tripos said.

The collaboration represents the first one of its kind for the ChemCore system, which incorporates Tripos’ MetaLayer technology, a company spokeswoman said.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

Oxford Nanopore Technologies is looking into dual listings in London and Hong Kong, according to the South China Morning Post.

The New York Times looks into medical research funding in the US and how the grant system might not be funding the best work.

US lawmakers proposed increasing the National Science Foundation budget, including its facilities account, Science reports.

In PNAS this week: effects of gene deletions on bacterial metabolic networks, genetic responses to sea star wasting disease, and more.